Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients

Chien-Te Lee1, Sarah Chua, Chung-Yao Hsu

  • 1Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. chientel@gmail.com

Disease Markers
|February 12, 2013
PubMed

Insights

Cardiovascular calcification is common in hemodialysis patients, particularly in heart valves. Risk factors vary by calcification type, with biomarkers like fetuin-A offering potential clinical insights.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Cardiovascular calcification (arterial intimal and medial calcification [AIC/AMC], valvular calcification [VC]) predicts outcomes in chronic dialysis patients.
  • Understanding prevalence and risk factors is crucial for managing hemodialysis (HD) patients.

Purpose of the Study:

  • Compare the prevalence of AIC, AMC, and VC in HD patients.
  • Analyze the distinct risk factors associated with each type of cardiovascular calcification.

Main Methods:

  • 81 HD patients underwent plain film radiography for vascular calcification and echocardiography for VC.
  • Demographic data and serum calcification-related biomarkers were collected and analyzed.
  • Patients with and without calcification were compared to identify associations.

Main Results:

  • Prevalence: AIC (44.4%), AMC (21%), VC (74.1%).
  • Vascular calcification associated with older age, diabetes, higher IL-6, osteoprotegerin, and uric acid.
  • VC associated with lower serum fetuin-A; AIC/AMC associated with age, diabetes, uric acid, and osteoprotegerin.

Conclusions:

  • Cardiovascular calcification is highly prevalent in chronic HD patients, with VC being most common.
  • Different calcification types (AIC, AMC, VC) have distinct associated risk factors.
  • Biomarker changes may aid in assessing cardiovascular calcification in HD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...